Global Breast Cancer Therapeutics Market to Focus on Developing Companion Diagnostics Models, Reports TMR Transparency Market Research states in a new report that the leading players in the global breast cancer therapeutics market will focus on developing companion diagnostics models to fortify their presence. As of 2014, the leading players in the global breast cancer therapeutics market were F.HoffmannLaRocheLtd., Astra Zeneca, and Novartis AG, who held a whopping share of 93.6%. Mergers and acquisitions will also shape the progress for the players in the overall market. Novartis took over the oncology drug GlaxoSmithKline in 2015, which will help the another 22 drugs including Tykerb to its pipeline.
trajectory of For instance, segment of company add
The lead author of this research report says, “New product launches and investments in clinical testing and trials are also expected to work in the favor of drug breast cancer therapeutics companies to diversify their portfolio and win bigger shares.� Increased Breast Cancer Risk to Pave Way for Steady Consumption of Breast Cancer Therapeutics